← Open Payments lookup

EMILY ANDREW: Open Payments

NPI 1861961369 · ALPINE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,419 in 60 payments from 14 companies in 2025. Trend: 2023 $1,361 · 2024 $1,703 · 2025 $1,419

Food & beverage: $1,419
CompanyPaymentsAmount
ABBVIE INC.18$315
Madrigal Pharmaceuticals6$197
Takeda Pharmaceuticals U.S.A., Inc.6$180
Janssen Biotech, Inc.8$180
GENZYME CORPORATION4$165
Celltrion USA Inc.5$99
Lilly USA, LLC2$52
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$49
Phathom Pharmaceuticals, Inc.2$38
QOL Medical, LLC2$35

Products named: REZDIFFRA, DUPIXENT, TREMFYA, ENTYVIO, RINVOQ, VEGZELMA, EOHILIA, LINZESS.

Industry payments across CA — which companies pay providers there.